Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer.
1/5 보강
[PURPOSE] Clinical research in pancreatic cancer (PC) has been limited because of a lack of granular data in national data sets.
APA
Ahmed KS, Marcinak CT, et al. (2026). Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer.. JCO clinical cancer informatics, 10, e2400265. https://doi.org/10.1200/CCI-24-00265
MLA
Ahmed KS, et al.. "Novel Electronic Health Record-Based Data Commons for Pancreatic Cancer.." JCO clinical cancer informatics, vol. 10, 2026, pp. e2400265.
PMID
41512230 ↗
Abstract 한글 요약
[PURPOSE] Clinical research in pancreatic cancer (PC) has been limited because of a lack of granular data in national data sets. An electronic health record (EHR)-based data set specifically designed for PC has immense potential to advance research. This study describes the creation of an EHR-based data commons for patients with PC.
[METHODS] We generated an index cohort of adult patients at our institution diagnosed with PC (International Classification of Diseases for Oncology, codes C25.0-25.9) between January 1, 2010, and December 31, 2023. To develop the Pancreatic Cancer Data Commons (PCDC), we linked six data sources: (1) institutional EHR data, (2) cancer-specific data from the North American Association of Central Cancer Registries, (3) surgical outcomes from the National Surgical Quality Improvement Program, (4) community-level data from the American Community Survey, (5) national mortality data from Obituary.com, and (6) genomic data from the cBioPortal for Cancer Genomics. We evaluated the feasibility of using the Observational Medical Outcomes Partnership common data model. The data set is stored on a cloud-based, Health Insurance Portability and Accountability Act-secure, and National Institute of Standards and Technology-compliant server.
[RESULTS] The PCDC currently includes data of 3,542 unique patients. The mean age at diagnosis is 66.6 ± 11.7 years; 53.3% is male, and 92.2% is White. Linkage to six national data sets increased the completeness of cancer-specific data from 31.3% to 71.6%. Most patients presented at stage IV (43.6%), followed by stage I (22.6%). As of the latest update, 1,074 (30.3%) patients were still alive.
[CONCLUSION] The PCDC is a centralized resource that solves a gap in PC research. The ability to securely link and analyze protected patient data is a strategic step toward enhancing clinical research and optimizing care for patients with PC. Our future work includes expanding the PCDC to multiple centers using common data models.
[METHODS] We generated an index cohort of adult patients at our institution diagnosed with PC (International Classification of Diseases for Oncology, codes C25.0-25.9) between January 1, 2010, and December 31, 2023. To develop the Pancreatic Cancer Data Commons (PCDC), we linked six data sources: (1) institutional EHR data, (2) cancer-specific data from the North American Association of Central Cancer Registries, (3) surgical outcomes from the National Surgical Quality Improvement Program, (4) community-level data from the American Community Survey, (5) national mortality data from Obituary.com, and (6) genomic data from the cBioPortal for Cancer Genomics. We evaluated the feasibility of using the Observational Medical Outcomes Partnership common data model. The data set is stored on a cloud-based, Health Insurance Portability and Accountability Act-secure, and National Institute of Standards and Technology-compliant server.
[RESULTS] The PCDC currently includes data of 3,542 unique patients. The mean age at diagnosis is 66.6 ± 11.7 years; 53.3% is male, and 92.2% is White. Linkage to six national data sets increased the completeness of cancer-specific data from 31.3% to 71.6%. Most patients presented at stage IV (43.6%), followed by stage I (22.6%). As of the latest update, 1,074 (30.3%) patients were still alive.
[CONCLUSION] The PCDC is a centralized resource that solves a gap in PC research. The ability to securely link and analyze protected patient data is a strategic step toward enhancing clinical research and optimizing care for patients with PC. Our future work includes expanding the PCDC to multiple centers using common data models.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (2)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.